July 23, 2026 07:22 AM GMT Chugai Pharmaceutical (4519) | Japan M Update Roche and Galderma 2Q26 Results: Slightly Positive for Chugai Key Takeaways On Jul 23, Roche (covered by Sarita Kapila) and Galderma (covered by Thibault Boutherin) reported 2Q26 results. Roche maintained its full-year guidance, while Galderma raised guidance. Others: Global Actemra sales declined 14% YoY in Apr-Jun, worsening from -4% in Jan-Mar. Enspryng has completed its US filing for TED and remains on track for a MOGAD filing in 2 ...